UF Health Pilot Program To Deliver COVID-19 Monoclonal Antibody Therapy to Rural Communities

A University of Florida Health pilot program will bring a new COVID-19 monoclonal antibody therapy to rural communities in North Florida.

As part of the White House’s Operation Warp Speed initiative, the U.S. Department of Health and Human Services selected UF Health and the UF Clinical and Translational Science Institute to coordinate the distribution and administration of 1,000 doses of bamlanivimab, a monoclonal antibody therapy, to eligible residents in rural North Florida communities.

“The goal of the program is to make sure that people living in rural communities have access to the latest COVID-19 therapies and important health information about COVID-19 therapeutics, testing and vaccines,” said Duane Mitchell, M.D., Ph.D., director of the UF CTSI, who is leading the collaborative effort to coordinate UF Health’s distribution and administration of the treatments with community education and awareness.

Learn more about UF Health Pilot Program To Deliver COVID-19 Monoclonal Antibody Therapy to Rural Communities.